Eli Lilly to acquire Centessa Pharmaceuticals in $7.8B strategic expansion into sleep medicine
Eli Lilly and Company (NYSE:LLY) announced a definitive agreement on Tuesday to acquire Centessa Pharmaceuticals, marking a significant strategic entry into the sleep medicine market.










